UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2012
Commission File Number: 1-32186
YM BIOSCIENCES INC. (Translation of registrant's name into English) |
Suite 400, Building 11 5045 Orbiter Drive Mississauga, Ontario Canada L4W 4Y4 (Address of principal executive offices) |
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F o | Form 40-F x |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) o
INCORPORATION BY REFERENCE
Exhibit 99.1 to this Form 6-K (other than the letter to shareholders appearing on page 1) is hereby incorporated by reference (i) into the Registration Statement on Form S-8 (File No. 333-134410 ) of YM BioSciences Inc. and (ii) as an exhibit to the Registration Statement on Form F-10 (File No. 333-170872) of YM Biosciences Inc.
DOCUMENTS FILED
See the Exhibit Index hereto.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| YM BIOSCIENCES INC. | ||
| By: | /s/ Leonard Vernon | |
Leonard Vernon Vice President, Finance and Administration | ||
Date: February 9, 2012
EXHIBIT INDEX
| Exhibit | Description | |
| 99.1 | Q2 Report | |
| 99.2 | CEO Certificate | |
| 99.3 | CFO Certificate |